Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
Multicenter, prospective, randomized studies.Evaluation of the sensitivity to different
chemotherapy regimens in platinum-partial sensitive recurrent ovarian cancer based on 11 gene
tests of homologous recombination pathway.